Removal of Endotoxin and Bacteria using the ELGA LabWater PURELAB® Chorus 1 fitted with a Point of use Filter (LC134 /LC145) or Biofilter (LC197)

Importance of the Topic

High-purity water free from biologically active contaminants such as endotoxins and bacteria is essential for sensitive life-science workflows. Residual lipopolysaccharides and microbial cells can compromise cell cultures, enzymatic assays, PCR amplification, electrophoresis, in vitro fertilization, and other critical applications. Reliable removal of these impurities ensures data integrity and operational reproducibility in research, quality control, and clinical laboratories.

Study Objectives and Overview

This study evaluates the performance of the ELGA LabWater PURELAB Chorus 1 Life Science system when equipped with a Point-of-Use (POU) filter (LC134/LC145) or a Biofilter (LC197). The primary goal is to verify the system’s ability to reduce endotoxin levels below 0.001 EU/ml and bacterial counts below 0.001 CFU/ml under stringent challenge conditions, thereby confirming its suitability for demanding biochemical and life-science applications.

Methodology and Instrumentation

• Water purification platform: PURELAB Chorus 1 Life Science incorporating reverse osmosis and UV recirculation.
• Final filtration modules: POU filters (LC134, LC145) and Biofilter (LC197) featuring positively charged resins for endotoxin adsorption.
• Endotoxin removal assay: Continuous challenge with high-concentration LPS suspensions generated from autoclaved and filtered Gram-negative bacteria; quantification via kinetic turbidimetric Limulus Amoebocyte Lysate (LAL) test.
• Bacterial removal test: Feed solutions prepared with peptone-grown bacteria; Total Viable Count measured by membrane filtration on R2A agar.
• TOC and resistivity measurements during initial rinse-up to assess organic leaching and conductivity recovery.

Main Results and Discussion

Under progressive endotoxin load up to ~800 000 EU, the Biofilter consistently achieved endotoxin levels below 0.001 EU/ml, corresponding to log reductions exceeding 5. Rinse-up trials demonstrated that TOC levels dropped below 10 ppb within the first 8 litres at 1 L/min flow, and resistivity returned above 17.5 MΩ·cm after minimal water passage. Bacterial challenges showed total viable counts reduced from 0.5–3.5 CFU/ml to below 0.001 CFU/ml, confirming log reductions greater than 7. These findings indicate stable performance and minimal contaminant breakthrough even under prolonged use.

Benefits and Practical Applications

• Production of endotoxin-free, bacteria-free water suitable for PCR, cell culture, electrophoresis, in vitro fertilization, and other life-science assays.
• Low-maintenance operation with rapid filter rinse-up, avoiding extended purge cycles.
• Compact point-of-use design enabling installation near instruments and eliminating post-filter monitoring concerns.

Future Trends and Applications

Ongoing developments may focus on integrated real-time sensors for endotoxin and microbial monitoring, enhanced filter chemistries for broader impurity classes, and modular miniaturized systems for point-of-care and field applications. Advances in membrane and resin technologies could further reduce system footprint and cost while improving throughput and longevity.

Conclusion

The PURELAB Chorus 1 Life Science system, equipped with POU filters or Biofilter LC197, delivers ultrapure water effectively free of endotoxin and bacterial contaminants. Its consistent performance under rigorous challenge conditions makes it a reliable solution for a wide range of sensitive biochemical and life-science processes.

Reference

1. Dawson M.E. (1998) LAL update. Associates of Cape Cod; Vol 16, 1–4
2. Nagano M., Takahashi Y., Katagiri S. (1999) Journal of Reproduction and Development 45, 239–242
3. Dumoulin J.C., Menheere P.P., Evers J.L. (1991) Human Reproduction 6, 730–734
4. Stacey G. (2007) Medicines from Animal Culture. In Stacey G. and Davis J. (eds.) John Wiley & Sons, Chapter 31